# SuperB Trial: SUrgical Versus PERcutaneous Bypass

> **NCT01220245** · NA · COMPLETED · sponsor: **Rijnstate Hospital** · enrollment: 129 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **PROCEDURE:** Heparin-bonded ePTFE endoluminal fem-pop bypass
- **PROCEDURE:** Surgical femoro-popliteal bypass.

## Key facts

- **NCT ID:** NCT01220245
- **Lead sponsor:** Rijnstate Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220245, "SuperB Trial: SUrgical Versus PERcutaneous Bypass". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01220245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*